Consumer court in Ernakulam orders ‘IVF clinic' to pay Rs 2.66L for misleading couple
The complaint was filed under Section 12 of the Consumer Protection Act, 1986.
The couple, married since 2002 and struggling with infertility, had attended a medical camp organized by the opposite party, M/s Broun Hall International India Pvt Ltd, at a hospital in Vadakara. There, Praveen Nair and Praveen Pillai—misrepresenting themselves as infertility specialists—promised a 100% success rate in IVF and urged immediate enrollment, citing high demand.
The commission stated that, according to the complainant, an initial advance of Rs 1,000 was collected at the camp, followed by Rs 2.4 lakh once the couple signed up for treatment.
However, after the payment was made, the clinic backtracked on its guarantees and demanded an additional Rs 40,000 for further tests. The couple complied, but later realised the treatment was a sham and that the clinic was more of a marketing outfit than a genuine medical provider.
When the promised treatment was not delivered and the refund denied, the couple approached the consumer court.
The commission bench—comprising DB Binu, V Ramachandran, and TN Srividya—ruled that the promised service was neither provided nor its 100% success guarantee fulfilled, resulting in financial loss and mental distress for the complainant. They stressed the need for strong intervention to protect consumers from such exploitative practices in the healthcare sector.
The court ordered the opposing party to return the Rs 2.41 lakh paid by the complainant and an additional Rs 25,000 for court costs and compensation, to be paid within 30 days.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
30 minutes ago
- India.com
Narayana Murthy, Sudha Murty pledges Rs 480000000 for noble cause of…, Infosys Foundation partners with…
Infosys Foundation, the philanthropic arm of IT giant Infosys, committed a grant of over Rs 48 crore to enhance healthcare infrastructure and services focused on maternal and child care in rural areas of Karnataka. Infosys Foundation has announced its partnership with UN-recognised organisation Prashanthi Balamandira Trust to this effect. Infosys Foundation Partnership With SMSIMSR The partnership will support the Sri Sathya Sai Sarla Memorial Hospital, a multi-speciality teaching facility affiliated with the Sri Madhusudan Sai Institute of Medical Sciences and Research (SMSIMSR), in delivering free healthcare services to underprivileged women, infants, and children. This initiative aims to improve access to quality maternal and child healthcare in rural areas of Karnataka, the company said in a regulatory filing. 'Through this collaboration, the Infosys Foundation has pledged a grant of over Rs 48 crore to augment healthcare infrastructure and facilities in maternal and child care services.'' How Will Infosys Foundation Help? 'This includes advanced medical equipment for obstetrics and gynecology, as well as to enhance medical facilities of the Neonatal Intensive Care Unit (NICU), Pediatric Intensive Care Unit (PICU), Intensive Care Unit (ICU), diagnostic radiology, and Operation Theatre (OT). 'A portion of the grant will also cover operational costs,' it said. The initiative is expected to benefit over 8,000 individuals annually. As a teaching institution, the hospital will also benefit from the new equipment by enabling training and upskilling of undergraduate and postgraduate doctors, as well as nursing and allied healthcare trainees, said SMSIMSR Founder Madhusudan Sai. (With Inputs From PTI)
News18
3 hours ago
- News18
Keep Your Cholesterol In Check: Here's What Doctors Wish You Knew About High LDL Cholesterol
Last Updated: Heart disease remains one of the leading causes of death in the country, accounting for nearly 7.8% of total mortalities Across the country, episodes of heart-related conditions like heart attacks are becoming increasingly common. But doctors are raising an alarm: high LDL cholesterol (also known as 'bad cholesterol") is showing up more frequently in India's younger population and it's a silent threat. Heart disease remains one of the leading causes of death in the country, accounting for nearly 7.8% of total mortalities. Behind many of these cases lies high LDL cholesterol, which plays a critical role in blocking arteries and triggering conditions like atherosclerosis and strokes. Dr. Sarita Rao, Senior Interventional Cardiologist and Director of Cathlab, Apollo Hospital, Indore, says, 'The role of LDL cholesterol (LDLC) in the development of atherosclerosis is well documented, where LDLC tends to accumulate and form plaque, creating blockages in the arteries and restricting blood flow. What makes it even more concerning is that high LDLC, like most heart conditions, doesn't show any symptoms. By the time there is chest pain or any warning sign, a cardiac event could already be underway and it may be too late. So, bringing high LDL cholesterol down to target levels is the primary objective for preventing serious heart conditions." Why Indians Need to Be Extra Cautious When compared to Western populations, Indians have been found to have higher levels of LDL cholesterol and lower levels of HDL cholesterol (the 'good" cholesterol that helps remove LDL from the bloodstream). This is why doctors recommend that cholesterol screening begin as early as 18 years of age. Early testing helps in detecting silent threats and allows one to take action before things escalate. People who may appear fit can still have high LDL cholesterol. 'I'm in my 30s, I work out regularly and eat clean," shares Delhi-based Ajay. 'I was confused and surprised when a routine test showed that I had high LDLC. My cardiologist explained that elevated LDL cholesterol could have various reasons and encouraged me to continue medical therapy alongside my healthy routine." It's Not Just About Eating Right We know that lifestyle modifications like a healthy diet, regular exercise, and stress management are essential but they're not always enough. Doctors emphasize that medical therapy should not be delayed or skipped, especially if your LDLC numbers are beyond the target range. Each patient's treatment journey is unique. Factors such as age, family history, diabetes status, or previous cardiac events all influence an individual's LDLC targets. This is why personalized treatment plans are crucial. It's important to seek professional medical advice and actively participate in treatment. However, in India, it's observed that only about 60% of patients adhere to their prescribed medication, a worrying trend. Misconceptions often lead people to stop their medication, which causes a rebound in LDL levels and heightens cardiovascular risk. Moreover, stress, poor sleep, and metabolic imbalances can also elevate LDLC levels. These factors contribute to chronic inflammation, prompting the body to produce more LDL cholesterol, thereby increasing the risk of a heart attack or stroke. When Lifestyle Isn't Enough – Advanced Therapy Is Key For patients who don't respond well to conventional statins, advanced therapies are increasingly being prescribed. Targeted treatments like PCSK9 inhibitors, siRNA therapy, or inclisiran show great promise in helping patients reach their target LDLC levels when standard options fall short. Always remember: high LDL cholesterol may not show symptoms but its consequences can be fatal. Whether you're a gym regular or someone who's never thought twice about your cholesterol, it's time to get screened, stay informed, and stick to your treatment plan for a healthier heart.
Hans India
4 hours ago
- Hans India
Costly outpatient services in corporate hospitals leave patients high and dry
Hyderabad: Inflatedcosts of outpatient services offered by private hospitals are leaving patients high and dry, including those who may have already spent a fortune as in-patient in the same hospital. Upon discharge, many in-patients are referred to in-house doctors who offer outpatient services during specified hours within the hospital premises. A portion of the high fees of such doctors goes to the hospital. This explains why they charge hefty sums ranging from Rs 1,000 to Rs 2,500 per visit. For other patients too, the same amount is charged by these in-house doctors, be they surgeons or physicians. Such squeezing takes place in corporate hospitals across the city and elsewhere due to the state medical authorities' laxity in regulating this aberration. Due to the lack of regulatory oversight, managements of corporate hospitals are raking in the moolah unethically as if they are not accountable to anybody. There was a time when outpatient services were economical than hospitalization, but now, due to now the rising charges, outpatient expenses are becoming a cause for concern for the common people. The hospitals are charging at least Rs 1,000 for normal OP services and amounts ranging from Rs 1,500 to Rs 3,000 for specialized consultations like cardiology, neurology, nephrology etc., depending on the size and 'brand value'of the hospital. Insurance cover is normally for in-patient services. However, the charges for outpatient services are draining their financial resources. Aside from high registration charges, patients are forced to pay indiscriminate and excessive charges for a battery of diagnostic tests prescribed by doctors. The woes of the patients do not end at registration and consultations but continue while they move out of the hospitals in the form of prescription of medicines. That apart, the doctors in such hospitals prescribe medicines that are only available in their in-house pharmacies, which are costly compared to the prices in outside medical shops. It may be mentioned here that the National Medical Commission (NMC) has issued guidelines asking doctors to prescribe drugs using generic names, avoid unnecessary medications and avoid irrational fixed dose combinations. The State Medical Councils have the authority to take disciplinary action against doctors who violate these regulations. The Supreme Court, while hearing a PIL plea, had suggested the states to introduce a policy so that hospitals do not compel patients to buy essential medical items from in-house pharmacies at inflated rates. Judge Justice Surya Kant highlighted concerns over patients being left with no choice but to purchase medicines, implants and medical devices at exorbitant prices from hospital-linked pharmacies. The Court noted that regulations in private healthcare remain inconsistent, leading to potential exploitation. The petitioner had argued that the practice leads to blackmailing, depriving patients of their rights to have fair pricing. K Shashikala (name changed), who wanted to see a senior endocrinologist for thyroid was asked to pay Rs 900 (Including 100 for registration) for walk-in consultation or Rs 1,000 for registration through phone. During their next visit to show their diagnostic report, they were asked to come to a corporate hospital if it was very urgent as the doctor provides the services there. The patient postponed the visit for two-three days to avoid paying the registration fee in the corporate hospital. When asked, a senior official from the Health Department, who did not want to be identified said that while the doctors have the right to prescribe the combinations as per the needs of the patients, the patients cannot be forced to take medicines from the in-house pharmacies. The official further said that the pricing of the outpatient consultations also depended on the facilities the hospital provided and the modern equipment they possessed.
